Next-generation sequencing with a myeloid gene panel in core-binding factor AML showed KIT activation loop and TET2 mutations predictive of outcome.
Cher CY, Leung GM, Au CH, Chan TL, Ma ES, Sim JP, Gill H, Lie AK, Liang R, Wong KF, Siu LL, Tsui CS, So CC, Wong HW, Yip SF, Lee HK, Liu HS, Lau JS, Luk TH, Lau CK, Lin SY, Kwong YL, Leung AY.
Cher CY, et al. Among authors: leung gm, leung ay.
Blood Cancer J. 2016 Jul 8;6(7):e442. doi: 10.1038/bcj.2016.51.
Blood Cancer J. 2016.
PMID: 27391574
Free PMC article.